Inertia Friction Welding of Dissimilar Superalloys Mar-M247 and LSHR von Senkov, Oleg N., Mahaffey, David W., Semiatin, S. Lee, Woodward, Christopher

Volltext

Milvexian for the Prevention of Venous Thromboembolism von Weitz, Jeffrey I, Strony, John, Ageno, Walter, Gailani, David, Hylek, Elaine M, Lassen, Michael R, Mahaffey, Kenneth W, Notani, Ravi S, Roberts, Robin, Segers, Annelise, Raskob, Gary E

Volltext

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acut... von Valgimigli, Marco, Costa, Francesco, Lokhnygina, Yuliya, Clare, Robert M, Wallentin, Lars, Moliterno, David J, Armstrong, Paul W, White, Harvey D, Held, Claes, Aylward, Philip E, Van de Werf, Frans, Harrington, Robert A, Mahaffey, Kenneth W, Tricoci, Pierluigi

Volltext

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial von Neal, Bruce, PhD, Perkovic, Vlado, PhD, de Zeeuw, Dick, PhD, Mahaffey, Kenneth W., MD, Fulcher, Greg, MD, Stein, Peter, MD, Desai, Mehul, MD, Shaw, Wayne, DSL, Jiang, Joel, PhD, Vercruysse, Frank, MD, Meininger, Gary, MD, Matthews, David, DPhil

Volltext

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes von Neal, Bruce, Perkovic, Vlado, Mahaffey, Kenneth W, de Zeeuw, Dick, Fulcher, Greg, Erondu, Ngozi, Shaw, Wayne, Law, Gordon, Desai, Mehul, Matthews, David R

Volltext

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial von Jardine, Meg J., Zhou, Zien, Mahaffey, Kenneth W., Oshima, Megumi, Agarwal, Rajiv, Bakris, George, Bajaj, Harpreet S., Bull, Scott, Cannon, Christopher P., Charytan, David M., de Zeeuw, Dick, Di Tanna, Gian Luca, Greene, Tom, Heerspink, Hiddo J. L., Levin, Adeera, Neal, Bruce, Pollock, Carol, Qiu, Rose, Sun, Tao, Wheeler, David C., Zhang, Hong, Zinman, Bernard, Rosenthal, Norman, Perkovic, Vlado

Volltext

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study) von Mahaffey, Kenneth W, Neal, Bruce, Perkovic, Vlado, de Zeeuw, Dick, Fulcher, Greg, Erondu, Ngozi, Shaw, Wayne, Fabbrini, Elisa, Sun, Tao, Li, Qiang, Desai, Mehul, Matthews, David R

Volltext

Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program von Neuen, Brendon L, Ohkuma, Toshiaki, Neal, Bruce, Matthews, David R, de Zeeuw, Dick, Mahaffey, Kenneth W, Fulcher, Greg, Li, Qiang, Jardine, Meg, Oh, Richard, Heerspink, Hiddo L, Perkovic, Vlado

Volltext

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics von Jardine, Meg J., Mahaffey, Kenneth W., Neal, Bruce, Agarwal, Rajiv, Bakris, George L., Brenner, Barry M., Bull, Scott, Cannon, Christopher P., Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Heerspink, Hiddo J.L., Levin, Adeera, Pollock, Carol, Wheeler, David C., Xie, John, Zhang, Hong, Zinman, Bernard, Desai, Mehul, Perkovic, Vlado

Volltext

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis von Neuen, Brendon L, Young, Tamara, Heerspink, Hiddo J L, Neal, Bruce, Perkovic, Vlado, Billot, Laurent, Mahaffey, Kenneth W, Charytan, David M, Wheeler, David C, Arnott, Clare, Bompoint, Severine, Levin, Adeera, Jardine, Meg J

Volltext

Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial von Neal, Bruce, Perkovic, Vlado, Matthews, David R., Mahaffey, Kenneth W., Fulcher, Greg, Meininger, Gary, Erondu, Ngozi, Desai, Mehul, Shaw, Wayne, Vercruysse, Frank, Yee, Jacqueline, Deng, Hsiaowei, de Zeeuw, Dick

Volltext

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials von Perkovic, Vlado, de Zeeuw, Dick, Mahaffey, Kenneth W, Fulcher, Greg, Erondu, Ngozi, Shaw, Wayne, Barrett, Terrance D, Weidner-Wells, Michele, Deng, Hsiaowei, Matthews, David R, Neal, Bruce

Volltext

Sodium-glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 Diabetes: A Meta-analysis of Individual Participant Data from Randomized Controlled Trials von Neuen, Brendon L, Oshima, Megumi, Agarwal, Rajiv, Arnott, Clare, Cherney, David Z, Edwards, Robert, Langkilde, Anna Maria, Mahaffey, Kenneth W, McGuire, Darren K, Neal, Bruce, Perkovic, Vlado, Pong, Annpey, Sabatine, Marc S, Raz, Itamar, Toyama, Tadashi, Wanner, Christoph, Wheeler, David C, Wiviott, Stephen D, Zinman, Bernard, Heerspink, Hiddo JL

Volltext

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program von Rådholm, Karin, Figtree, Gemma, Perkovic, Vlado, Solomon, Scott D, Mahaffey, Kenneth W, de Zeeuw, Dick, Fulcher, Greg, Barrett, Terrance D, Shaw, Wayne, Desai, Mehul, Matthews, David R, Neal, Bruce

Volltext

Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus: Results From the CANVAS Program von Figtree, Gemma A, Rådholm, Karin, Barrett, Terrance D, Perkovic, Vlado, Mahaffey, Kenneth W, de Zeeuw, Dick, Fulcher, Greg, Matthews, David R, Shaw, Wayne, Neal, Bruce

Volltext

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial von Oshima, Megumi, Neuen, Brendon L., Li, JingWei, Perkovic, Vlado, Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Levin, Adeera, Mahaffey, Kenneth W., De Nicola, Luca, Pollock, Carol, Rosenthal, Norman, Wheeler, David C., Jardine, Meg J., Heerspink, Hiddo J. L.

Volltext

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice von Oshima, Megumi, Jardine, Meg J., Agarwal, Rajiv, Bakris, George, Cannon, Christopher P., Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Levin, Adeera, Lim, Soo Kun, Mahaffey, Kenneth W., Neal, Bruce, Pollock, Carol, Rosenthal, Norman, Wheeler, David C., Zhang, Hong, Zinman, Bernard, Perkovic, Vlado, Heerspink, Hiddo J.L.

Volltext

Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data from the CANVAS Program von Neuen, Brendon L, Ohkuma, Toshiaki, Neal, Bruce, Matthews, David R, de Zeeuw, Dick, Mahaffey, Kenneth W, Fulcher, Greg, Desai, Mehul, Li, Qiang, Deng, Hsiaowei, Rosenthal, Norm, Jardine, Meg J, Bakris, George, Perkovic, Vlado

Volltext

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation von Perez, Marco V, Mahaffey, Kenneth W, Hedlin, Haley, Rumsfeld, John S, Garcia, Ariadna, Ferris, Todd, Balasubramanian, Vidhya, Russo, Andrea M, Rajmane, Amol, Cheung, Lauren, Hung, Grace, Lee, Justin, Kowey, Peter, Talati, Nisha, Nag, Divya, Gummidipundi, Santosh E, Beatty, Alexis, Hills, Mellanie True, Desai, Sumbul, Granger, Christopher B, Desai, Manisha, Turakhia, Mintu P

Volltext

Mechanical Complications After Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction (from APEX-AMI) von French, John K., MBChB, PhD, Hellkamp, Anne S., MS, Armstrong, Paul W., MD, Cohen, Eric, MD, Kleiman, Neil S., MD, O'Connor, Christopher M., MD, Holmes, David R., MD, Hochman, Judith S., MD, Granger, Christopher B., MD, Mahaffey, Kenneth W., MD

Volltext